Horn Margaret A sold $1.5M of RVMD
Horn Margaret A (Chief Operating Officer) sold 10,000 shares of Revolution Medicines, Inc. (RVMD) at an average of $148.01 ($144.28–$150.17, $1.48M total) across 7 trades on 2026-06-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A COO open-market sale of 10,000 shares (~$1.48M) was executed across multiple trades at ~$144.28–$150.17, under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor for follow-on insider activity, but the 10b5-1 structure suggests limited incremental information.
What to watch
Insider sales can be routine; without accompanying buy/sell by other insiders or new clinical/financial catalysts, price reaction is likely muted.
Background
The article is an SEC Form 4 insider transaction disclosure for Revolution Medicines, Inc. (RVMD).
Ticker impact
SEC Form 4 shows COO Margaret Horn sold ~$1.48M of Revolution Medicines shares via an open-market sale under a 10b5-1 plan.
Likely limited/short-lived impact; any move would be more sentiment-driven than fundamental.
The filing is primary-source and transaction size is moderate, but 10b5-1 pre-arrangement typically dampens interpretability versus discretionary selling.
Market effects
No direct sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
The sale may be purely liquidity/portfolio rebalancing under a scheduled 10b5-1 plan, so it may not reflect negative fundamentals.
Key entities
- issuerRevolution Medicines, Inc.
Subject of the SEC Form 4 insider transaction disclosure.
- insiderHorn Margaret A
Chief Operating Officer who sold shares via open-market sale under a 10b5-1 plan.
